ImmunityBio (IBRX) Market Capitalization (2015 - 2026)
ImmunityBio's Market Capitalization came in at $9.23 billion for Q2 2026, up 281.7% from $2.42 billion a year earlier and up 14.9% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Market Capitalization (2015 - 2026) Analysis & Trends
For FY2025, ImmunityBio's Market Capitalization was $2 billion, up 12.2% from FY2024.
- Market Capitalization carries a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
- Going back by year, Market Capitalization was $1.79 billion in FY2024 (-30.1%), $2.55 billion in FY2023 (+19.5%), $2.14 billion in FY2022 (-11.6%) and $2.42 billion in FY2021 (+75.2%).
- The Q2 2026 figure represents the highest quarterly Market Capitalization in data going back to Q3 2015.
- Year-over-year, Market Capitalization has increased for three consecutive quarters, with growth averaging 75.5% over the last eight quarters.
- The fastest year-over-year change in Market Capitalization over five years came in Q3 2021 (growth of 410.6%), and the weakest in Q1 2022 (a decline of 75.5%).
- Business Quant data shows IBRX's Market Capitalization at $8.03 billion (Q1 2026), $2 billion (Q4 2025) and $2.42 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | ImmunityBio | 9.07 Bn | 7.83 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.23 Bn |
| Mar 31, 2026 | 8.03 Bn |
| Dec 31, 2025 | 2.00 Bn |
| Sep 30, 2025 | 2.42 Bn |
| Jun 30, 2025 | 2.42 Bn |
| Mar 31, 2025 | 2.57 Bn |
| Dec 31, 2024 | 1.79 Bn |
| Sep 30, 2024 | 2.59 Bn |
| Jun 30, 2024 | 4.37 Bn |
| Mar 31, 2024 | 3.64 Bn |
| Dec 31, 2023 | 2.55 Bn |
| Sep 30, 2023 | 842.25 Mn |
| Jun 30, 2023 | 1.23 Bn |
| Mar 31, 2023 | 767.26 Mn |
| Dec 31, 2022 | 2.14 Bn |
| Sep 30, 2022 | 1.99 Bn |
| Jun 30, 2022 | 1.48 Bn |
| Mar 31, 2022 | 2.23 Bn |
| Dec 31, 2021 | 2.42 Bn |
| Sep 30, 2021 | 3.84 Bn |
API Access
ImmunityBio Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();